Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 13

    2.

    Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling.

    Tan YM, Liao KH, Clewell HJ 3rd.

    J Expo Sci Environ Epidemiol. 2007 Nov;17(7):591-603. Epub 2006 Nov 15.PMID: 17108893 [PubMed - indexed for MEDLINE]Related articles

    3.

    The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene.

    Covington TR, Robinan Gentry P, Van Landingham CB, Andersen ME, Kester JE, Clewell HJ.

    Regul Toxicol Pharmacol. 2007 Feb;47(1):1-18. Epub 2006 Aug 9.PMID: 16901594 [PubMed - indexed for MEDLINE]Related articles

    4.

    Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.

    Hack CE, Chiu WA, Jay Zhao Q, Clewell HJ.

    Regul Toxicol Pharmacol. 2006 Oct;46(1):63-83. Epub 2006 Aug 4.PMID: 16889879 [PubMed - indexed for MEDLINE]Related articles

    5.

    Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform.

    Tan YM, Liao KH, Conolly RB, Blount BC, Mason AM, Clewell HJ.

    J Toxicol Environ Health A. 2006 Sep;69(18):1727-56.PMID: 16864423 [PubMed - indexed for MEDLINE]Related articles

    6.

    Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.

    Marino DJ, Clewell HJ, Gentry PR, Covington TR, Hack CE, David RM, Morgott DA.

    Regul Toxicol Pharmacol. 2006 Jun;45(1):44-54. Epub 2006 Jan 25.PMID: 16442684 [PubMed - indexed for MEDLINE]Related articles

    7.

    Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study.

    Sohn MD, McKone TE, Blancato JN.

    J Expo Anal Environ Epidemiol. 2004 May;14(3):204-13.PMID: 15141149 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bayesian internal dosimetry calculations using Markov Chain Monte Carlo.

    Miller G, Martz HF, Little TT, Guilmette R.

    Radiat Prot Dosimetry. 2002;98(2):191-8.PMID: 11926369 [PubMed - indexed for MEDLINE]Related articles

    9.

    Statistical issues in toxicokinetic modeling: a bayesian perspective.

    Bernillon P, Bois FY.

    Environ Health Perspect. 2000 Oct;108 Suppl 5:883-93.PMID: 11035998 [PubMed - indexed for MEDLINE]Related articles

    11.

    Physiological parameter values for physiologically based pharmacokinetic models.

    Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP.

    Toxicol Ind Health. 1997 Jul-Aug;13(4):407-84. Review. No abstract available. PMID: 9249929 [PubMed - indexed for MEDLINE]Related articles

    12.

    Markov chain Monte Carlo methods in biostatistics.

    Gelman A, Rubin DB.

    Stat Methods Med Res. 1996 Dec;5(4):339-55.PMID: 9004377 [PubMed - indexed for MEDLINE]Related articles

    13.

    Studies of multiroute exposure/dose reconstruction using physiologically based pharmacokinetic models.

    Roy A, Weisel CP, Gallo MA, Georgopoulos PG.

    Toxicol Ind Health. 1996 Mar-Apr;12(2):153-63. No abstract available. PMID: 8794529 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data